课题基金 / 基金详情

Behavioral and neurochemical studies of schizophrenia using an animal model of the phychosis.

Behavioral and neurochemical studies of schizophrenia using an animal model of the phychosis.
使用精神病动物模型对精神分裂症进行行为和神经化学研究。
批准号:
07671042
负责人:
OHMORI Tetsuro
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

OHMORI Tetsuro的其他基金

相似基金

相关文献

中文摘要
翻译
反复服用甲基苯丙胺会导致人类出现精神分裂样窒息,并导致动物的行为敏感化。对行为敏感化的理解可能有助于了解甲基苯丙胺诱导的窒息和精神分裂症的发病机制。1)在小笼子里重复接受甲基苯丙胺的大鼠没有表现出运动活动的增强,但表现出刻板行为的增强,这表明环境改变了行为敏化的表达。2)M胆碱能受体的拮抗剂东莨菪碱阻止了行为敏化的发生。中枢胆碱能受体似乎在行为敏感化的发展中起作用。3)氯硝西潘和中枢GABA-苯二氮卓类受体的激动剂,可阻止行为敏感化。中枢GABA神经传递似乎在行为敏化的发展中起作用。这些结果与谷氨酸拮抗剂和蛋白质合成抑制剂也阻止敏化的报道相结合,可能表明行为敏化与学习和记忆等其他神经可塑性变化具有一些共同的性质。
英文摘要
Repeated administration of methamphetamine results in schizophrenia-like phychosis in human and behavioral sensitization in animals. Understanding of behavioral sensitization may provide insight into the pathogenesis of both methamphetamine-induced phychosis and schizophrenia.1) Rats repeatedly received methamphetamine in a small cage did not show enhancement in locomotoer activity but showed enhancement in stereotyped behavior, suggesting that environment modifies the expression of behavioral sensitization.2) Scopolamine, an antagonist of muscarinic cholinergic receptors, prevented behavioral sensitization. Central cholinergic receptors seem to play a role in the development of behavioral sensitization.3) Clonazepam, and agonist of central GABA-benzodiazepine receptors, prevented behavioral sensitization. Central GABA neurotransmission seems to play a role in the development of behavioral sensitization.These results, taken together with the reports showing glutamate antagonists and protein synthesis inhibitors also prevent sensitization, may indicate that behavioral sensitization have some common properties with other neural plastic change such as learning and memory.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
T.Ohmori, T.Abekawa, T.Koyama: "Scopolamine prevents the augmentation of stereotypy produced by chronic methamphetamine treatment." Psychopharmacology. 121. 158-163 (1995)
T.Ohmori、T.Abekawa、T.Koyama:“东莨菪碱可以防止长期甲基苯丙胺治疗所产生的刻板印象的增强。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Ohmori.T.Abekawa and T.Koyama.: "Scopolamine prevents the development of behavioral sensitization to methamphetamine" Life Science. 56. 1223-1229 (1995)
T.Ohmori.T.Abekawa 和 T.Koyama.:“东莨菪碱可防止对甲基苯丙胺行为过敏的发展”生命科学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Establishment of biological marker and pathophysiological study of depression using omics analysis
    • 批准号:
      18H02751
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2018
    • 负责人:
      OHMORI Tetsuro
    • 依托单位:
    Effects of psychotropic drugs on the amino acid system in the brain: psychopharmacological application of high magnetic field MRS.
    • 批准号:
      26461719
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      OHMORI Tetsuro
    • 依托单位:
    Clinical and neuroscientific study of schizophrenia with reference to cognitive function and QOL.
    • 批准号:
      21591520
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      OHMORI Tetsuro
    • 依托单位:
    Evaluation of pharmacotherapy with reference to QOL and the analysis of therapeutic drug response.
    • 批准号:
      16390325
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.91万
    • 财政年份:
      2004
    • 负责人:
      OHMORI Tetsuro
    • 依托单位:
    海外基金